Tokyo Tape
Sign in
← Techmatrix

Quarterly report · Q2

3762.TEDINET S100PLJ0
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
MetricValuePeriodScopeSource row
Revenue¥20.7bn2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥10.9bn2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥36.5bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥16.1bn2021-04-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥8.5bn2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income¥1.9bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥1.0bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥1.6bn2021-04-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥954m2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥1.9bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥1.0bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥3.7bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥1.6bn2021-04-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥951m2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥1.1bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥561m2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥2.4bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥1.0bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥618m2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥1.3bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥682m2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥2.6bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥1.1bn2021-04-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥661m2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥60.8bnat 2022-09-30Cons.Assets IFRS
Total assets¥52.5bnat 2022-03-31Cons.Assets IFRS
Total assets¥42.5bnat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥38.9bnat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥32.3bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥21.8bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥20.2bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥17.0bnat 2021-09-30Cons.Equity IFRS
Net assets / equity¥16.4bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥17.4bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥17.0bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥15.4bnat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥19.2bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥18.2bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥14.2bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥14.6bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥2.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥5.3bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥1.4bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥1.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥196m2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥726m2021-04-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥319m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥2.0bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥1.1bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥26.652022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥14.062022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥59.652021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥26.322021-04-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥15.562021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥26.572022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥14.022022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥59.462021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥26.242021-04-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥15.512021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio28.6%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio32.4%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio36.2%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥175m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥175m
jpcrp040300-q2r_E05463-000Application Servicereportable segmentrevenue2022-04-01 → 2022-09-30¥3.4bn
jpcrp040300-q2r_E05463-000Application Servicereportable segmentrevenue external2022-04-01 → 2022-09-30¥3.4bn
jpcrp040300-q2r_E05463-000Application Servicereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥65m
jpcrp040300-q2r_E05463-000Application Servicereportable segmentsegment profit2022-04-01 → 2022-09-30−¥98m
jpcrp040300-q2r_E05463-000Information Infrastructurereportable segmentrevenue2022-04-01 → 2022-09-30¥13.5bn
jpcrp040300-q2r_E05463-000Information Infrastructurereportable segmentrevenue external2022-04-01 → 2022-09-30¥13.4bn
jpcrp040300-q2r_E05463-000Information Infrastructurereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥108m
jpcrp040300-q2r_E05463-000Information Infrastructurereportable segmentsegment profit2022-04-01 → 2022-09-30¥1.3bn
jpcrp040300-q2r_E05463-000Medical System Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥4.0bn
jpcrp040300-q2r_E05463-000Medical System Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥4.0bn
jpcrp040300-q2r_E05463-000Medical System Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥2m
jpcrp040300-q2r_E05463-000Medical System Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥748m
—segment totalrevenue2022-04-01 → 2022-09-30¥20.9bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥20.7bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥175m
—segment totalsegment profit2022-04-01 → 2022-09-30¥1.9bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥179m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥179m
jpcrp040300-q2r_E05463-000Application Servicereportable segmentrevenue2021-04-01 → 2021-09-30¥3.4bn
jpcrp040300-q2r_E05463-000Application Servicereportable segmentrevenue external2021-04-01 → 2021-09-30¥3.3bn
jpcrp040300-q2r_E05463-000Application Servicereportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥35m
jpcrp040300-q2r_E05463-000Application Servicereportable segmentsegment profit2021-04-01 → 2021-09-30−¥32m
jpcrp040300-q2r_E05463-000Information Infrastructurereportable segmentrevenue2021-04-01 → 2021-09-30¥11.4bn
jpcrp040300-q2r_E05463-000Information Infrastructurereportable segmentrevenue external2021-04-01 → 2021-09-30¥11.3bn
jpcrp040300-q2r_E05463-000Information Infrastructurereportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥130m
jpcrp040300-q2r_E05463-000Information Infrastructurereportable segmentsegment profit2021-04-01 → 2021-09-30¥1.4bn
jpcrp040300-q2r_E05463-000Medical System Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥1.5bn
jpcrp040300-q2r_E05463-000Medical System Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥1.5bn
jpcrp040300-q2r_E05463-000Medical System Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥14m
jpcrp040300-q2r_E05463-000Medical System Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥253m
—segment totalrevenue2021-04-01 → 2021-09-30¥16.3bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥16.1bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥179m
—segment totalsegment profit2021-04-01 → 2021-09-30¥1.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 791
ItemContextValueUnit
Net increase decrease in short term borrowings fin cf IFRSPrior1YTDDuration-100000000JPY
Net increase decrease in short term borrowings fin cf IFRSCurrentYTDDuration-25000000JPY
Repayments of long term borrowings fin cf IFRSPrior1YTDDuration-103483000JPY
Repayments of long term borrowings fin cf IFRSCurrentYTDDuration-100000000JPY
Dividends paid fin cf IFRSPrior1YTDDuration-476200000JPY
Dividends paid fin cf IFRSCurrentYTDDuration-518209000JPY
Repayments of lease obligations fin cf IFRSPrior1YTDDuration-428137000JPY
Repayments of lease obligations fin cf IFRSCurrentYTDDuration-620253000JPY
Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRSPrior1YTDDuration－JPY
Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRSCurrentYTDDuration-248475000JPY
Proceeds from changes in ownership interests in subsidiaries that do not result in loss of control fin cf IFRSPrior1YTDDuration－JPY
Proceeds from changes in ownership interests in subsidiaries that do not result in loss of control fin cf IFRSCurrentYTDDuration1200577000JPY
Other fin cf IFRSPrior1YTDDuration-3169000JPY
Other fin cf IFRSCurrentYTDDuration-7881000JPY
Net cash provided by used in financing activities IFRSPrior1YTDDuration-1110990000JPY
Net cash provided by used in financing activities IFRSCurrentYTDDuration-319242000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSPrior1YTDDuration108000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSCurrentYTDDuration1530000JPY
Net increase decrease in cash and cash equivalents IFRSPrior1YTDDuration-425743000JPY
Net increase decrease in cash and cash equivalents IFRSCurrentYTDDuration1060703000JPY
Cash and cash equivalents IFRSPrior2YearInstant14634332000JPY
Cash and cash equivalents IFRSPrior1YearInstant18155903000JPY
Cash and cash equivalents IFRSPrior1QuarterInstant14208589000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant19216606000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E05463-000InformationInfrastructureReportableSegmentMember11289842000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E05463-000ApplicationServiceReportableSegmentMember3337316000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E05463-000MedicalSystemBusinessReportableSegmentMember1519467000JPY
Revenue from external customers IFRSPrior1YTDDuration_ReportableSegmentsMember16146626000JPY
Revenue from external customers IFRSPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenue from external customers IFRSPrior1YTDDuration16146626000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E05463-000InformationInfrastructureReportableSegmentMember130370000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E05463-000ApplicationServiceReportableSegmentMember34624000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E05463-000MedicalSystemBusinessReportableSegmentMember14017000JPY
Intersegment revenue IFRSPrior1YTDDuration_ReportableSegmentsMember179012000JPY
Intersegment revenue IFRSPrior1YTDDuration_ReconcilingItemsMember-179012000JPY
Intersegment revenue IFRSPrior1YTDDuration－JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E05463-000InformationInfrastructureReportableSegmentMember11420213000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E05463-000ApplicationServiceReportableSegmentMember3371940000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E05463-000MedicalSystemBusinessReportableSegmentMember1533484000JPY
Revenue IFRSPrior1YTDDuration_ReportableSegmentsMember16325638000JPY
Revenue IFRSPrior1YTDDuration_ReconcilingItemsMember-179012000JPY
Revenue IFRSPrior1YTDDuration16146626000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q2r_E05463-000InformationInfrastructureReportableSegmentMember1379991000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q2r_E05463-000ApplicationServiceReportableSegmentMember-32002000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q2r_E05463-000MedicalSystemBusinessReportableSegmentMember253143000JPY
Operating profit loss IFRSPrior1YTDDuration_ReportableSegmentsMember1601132000JPY
Operating profit loss IFRSPrior1YTDDuration_ReconcilingItemsMember－JPY
Operating profit loss IFRSPrior1YTDDuration1601132000JPY
Finance income IFRSPrior1YTDDuration9975000JPY
Finance costs IFRSPrior1YTDDuration11385000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass